Nona Biosciences’ ADC Technology Dr. Jingsong Wang delves into the cutting-edge world of Antibody-Drug Conjugate (ADC) technology and its pivotal role in advancing cancer treatment. The conversation spanned Nona biosciences as a global technology platform company that specializes in the biologics area, offering partnership opportunities worldwide.